This study aimed to evaluate the expression of TRIM8 and its associated ncRNAs (lnc-SSBP2-1:1 and hsa-miR-126-5p) as potential biomarkers for LN activity and disease severity. This evidence concerns the gene SSBP2 and lobular neoplasia.